Abstract:Autophagy is a vital catabolic mechanism to degrade and recycle long-lived proteins and useless organelles relying on lysosomes (Xu andWan, 2023). Since its initially discovered and reported in the 1960s, the biological characteristics and functions have been largely investigated. So far, several kinds of autophagy have been uncovered, including classic autophagy (including microautophagy, chaperonemediated autophagy, and macroautophagy) and selective autophagy (including pexophagy, mitophagy, xenophagy, and reticulophagy, etc.) (Shao et al., 2022; Shao et al., 2023; Wang et al., 2023). The general process of autophagy is elucidated, including the formation of phagophores and subsequently autophagosomes with the involvement of autophagy-related genes (ATGs), and the mature of autolysosomes with the integration of autophagosomes and lysosomes (Deretic, 2021; Shao et al., 2022). So far, autophagy has been widely revealed to be closely involved in the pathogenesis and progression of various kinds of inflammation-related diseases. For instance, it was previously reported by studies from us and others that autophagy contributed to alleviate the severity of multiple sclerosis through the suppression of the NLRP3 inflammasome assembly and activation (Shao et al., 2014; Cheng et al., 2020). In addition, autophagy was also shown to be involved in the regulation of other inflammation-related diseases including inflammatory bowel diseases, atherosclerosis, stroke, myocardial infarction, etc., (Sorice, 2022; Yamamoto et al., 2023). Based on such knowledge, we ran another Research Topic about autophagy and inflammation-related diseases entitled “Autophagy in Inflammation Related Diseases, Volume II” to collect related studies for the discussion of such issue. In our Research Topic, six brilliant studies have been collected and officially published in Frontiers in pharmacology. Among them, Wang et al. revealed that aspirin-triggered Resolvin D1 (AT-RvD1) produced an alleviative effect on neuropathic pain through the induction of autophagy-mediated suppression of the NLRP3 inflammasome. In addition, Pei et al. demonstrated that alantolactone attenuated interleukin (IL)-1β-induced inflammatory responses, relieved cartilage degeneration and promoted impaired autophagy via restraining of signal transducer and activator of transcription 3 (STAT3) and nuclear factor (NF)-κB signaling pathways in osteoarthritis. In a review paper, Feng et al. reported that autophagy was involved in the regulation of heparinase-mediated promotion of coagulation disorder OPEN ACCESS

Aspirin-triggered Resolvin D1 ameliorates activation of the NLRP3 inflammasome via induction of autophagy in a rat model of neuropathic pain

Protective Actions of Aspirin-Triggered (17R) Resolvin D1 and Its Analogue, 17R-Hydroxy-19-para-fluorophenoxy-resolvin D1 Methyl Ester, in C5a-Dependent IgG Immune Complex–Induced Inflammation and Lung Injury

The Involvement of Spinal Annexin A10/NF-κB/MMP-9 Pathway in the Development of Neuropathic Pain in Rats

Resolvin D1 alleviates mechanical allodynia via ALX/FPR2 receptor targeted NLRP3/ERK signaling in a neuropathic pain model

Resveratrol mediates mechanical allodynia through modulating inflammatory response via the TREM2-autophagy axis in SNI rat model

Resveratrol Attenuates Inflammatory Hyperalgesia by Inhibiting Glial Activation in Mice Spinal Cords

Protective Effects of Resveratrol on Autologous Nucleus Pulposus Model of Radiculopathy.

Electroacupuncture Ameliorates Mechanical Allodynia of a Rat Model of CRPS-I Via Suppressing NLRP3 Inflammasome Activation in Spinal Cord Dorsal Horn Neurons

Resolvin D1 Reverses Chronic Pancreatitis-Induced Mechanical Allodynia, Phosphorylation of Nmda Receptors, and Cytokines Expression in the Thoracic Spinal Dorsal Horn

Resolvin D1 programs inflammation resolution by increasing TGF-β expression induced by dying cell clearance in experimental autoimmune neuritis.

Resolvin D1/N-formyl peptide receptor 2 ameliorates paclitaxel-induced neuropathic pain through the activation of IL-10/Nrf2/HO-1 pathway in mice

Resolvin D1 Induces mTOR-independent and ATG5-dependent Autophagy in BV-2 Microglial Cells

Resolving TRPV1- and TNF-α-mediated Spinal Cord Synaptic Plasticity and Inflammatory Pain with Neuroprotectin D1.

ANA-12 Promotes Astrocyte Autophagy in Neuropathic Pain by Modulating TRKB/mTOR/c-JUN Axis

A Novel Mechanism of Specialized Proresolving Lipid Mediators Mitigating Radicular Pain: The Negative Interaction with NLRP3 Inflammasome

Editorial: Autophagy in Inflammation Related Diseases

Resveratrol inhibited the formation of NLRP 3 inflammatory body by activating autophagy signal pathway in atherosclerosis

Receptor-Interacting Protein Kinase 3 Inhibition Relieves Mechanical Allodynia and Suppresses NLRP3 Inflammasome and NF-?B in a Rat Model of Spinal Cord Injury

Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models

Resolvin D1 attenuates depressive-like behavior in LPS-challenged mice by promoting microglial autophagy

Receptor-Interacting Protein Kinase 3 Inhibition Relieves Mechanical Allodynia and Suppresses NLRP3 Inflammasome and NF-κB in a Rat Model of Spinal Cord Injury